CN113082113A - 一种中西医结合清热解毒的外用药 - Google Patents

一种中西医结合清热解毒的外用药 Download PDF

Info

Publication number
CN113082113A
CN113082113A CN202110371368.9A CN202110371368A CN113082113A CN 113082113 A CN113082113 A CN 113082113A CN 202110371368 A CN202110371368 A CN 202110371368A CN 113082113 A CN113082113 A CN 113082113A
Authority
CN
China
Prior art keywords
parts
component
medicine
ointment
raw materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110371368.9A
Other languages
English (en)
Inventor
许青松
许雨越
许宇豪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110371368.9A priority Critical patent/CN113082113A/zh
Publication of CN113082113A publication Critical patent/CN113082113A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种中西医结合清热解毒的外用药，包括野枸杞根，白狗屎，大黄，枯矾等。本发明具有消炎、清热、解毒、祛痂、收敛、止血、抗感染以及杀菌止痒的效果。治疗效果好，治疗速度快，可以在快速消除炎症反应，使患处恢复健康。

Description

一种中西医结合清热解毒的外用药
技术领域
本发明涉及中药领域，具体涉及一种中西医结合清热解毒的外用药。
背景技术
鼻炎、中耳炎、烂嘴角以及口腔溃疡是人们常见的炎症。这些炎症发病的病程长，难以治愈，为人们带来较大痛苦，并且严重影响人们的生活质量。
上述炎症主要由于体内热毒积聚导致，体内热毒还容易导致体癣、股癣、头癣，以及阴痒、毛囊炎、湿疹、皮炎等问题。而现有方案中并没有有效治疗对应症状的方法。
发明内容
本发明的目的在于克服上述问题，提供了一种中西医结合消炎杀菌外用药。为实现上述目的，本发明采用如下技术方案：
一种中西医结合消炎杀菌外用药，包括组分A，组分B和组分C，各组分以重量份数计包括如下成分：
组分A：野枸杞根15-40份，白狗屎10-20份，大黄10-20份，枯矾5-15份，冰片5-15份，樟脑5-15份；
组分B：地塞米松针剂1-6份，菌必治针剂1-2份，病毒唑针剂1-5份，维生素C 0.5-1份；
组分C：风油精1-3份，红霉素眼膏1-3份，华佗膏1-5份，复方酮康唑乳膏1-5份，狼毒软膏1-5份。
本发明还公开了一种中西医结合消炎杀菌外用药的制作方法，包括如下步骤：
S1.将组分A中的各原料磨碎打粉，混合均匀后，加香油拌匀成膏剂；
S2.将组分B中的各原料加入生理盐水中稀释，然后加入喷雾瓶内备用；
S3.将组分C中的各原料按比例混合，搅拌均匀备用。
作为改进，所述药物的使用方法为先使用组分B的喷雾均匀喷洒至患处，然后分别将组分A或组分C的膏剂抹入患处，每日3-4次。
本发明的优点在于：
本发明具有消炎、清热、解毒、祛痂、收敛、止血、抗感染以及杀菌止痒的效果。主要治疗：鼻炎，中耳炎，烂嘴，口腔溃疡，牙龈出血，小儿黄水疮，烧烫伤。并且方案对体癣，股癣，头癣，花斑癣，钱癣，大腿夹癣，脚癣，手癣，牛皮癣，绣球瘙痒症，阴痒，毛囊炎，湿疹，皮炎，手足皲裂，鹅掌风水痘等。
本发明治疗效果好，治疗速度快，可以在快速消除炎症反应，使患处恢复健康。
具体实施方式
下面通过具体实施例对本发明进行详细和具体的介绍，以使更好的理解本发明，但是下述实施例并不限定本发明的保护范围。
实施例1
本实施例公开了一种中西医结合消炎杀菌外用药，包括组分A，组分B和组分C，各组分以重量份数计包括如下成分：
组分A：野枸杞根30g，白狗屎20g，大黄10g，枯矾5g，冰片5g，樟脑5g；
组分B：地塞米松针剂2g，菌必治针剂1g，病毒唑针剂1g，维生素C1g；
组分C：风油精2g，红霉素眼膏2g，华佗膏1g，复方酮康唑乳膏1g，狼毒软膏1g。
本实施例的制作方法，包括如下步骤：
S1.将组分A中的各原料磨碎打粉，混合均匀后，加香油拌匀成膏剂；
S2.将组分B中的各原料加入生理盐水中稀释，然后加入喷雾瓶内备用；
S3.将组分C中的各原料按比例混合，搅拌均匀备用。
本实施例的使用方法为：先使用组分B的喷雾均匀喷洒至患处，然后分别将组分A或组分C的膏剂抹入患处，每日3-4次。
实施例2
本实施例公开了一种中西医结合消炎杀菌外用药，包括组分A，组分B和组分C，各组分以重量份数计包括如下成分：
组分A：野枸杞根40g，白狗屎10g，大黄20g，枯矾15g，冰片15g，樟脑15g；
组分B：地塞米松针剂6g，菌必治针剂2g，病毒唑针剂5g，维生素C 0.5g；
组分C：风油精3g，红霉素眼膏3g，华佗膏5g，复方酮康唑乳膏5g，狼毒软膏5g。
实施例3
本实施例公开了一种中西医结合消炎杀菌外用药，包括组分A，组分B和组分C，各组分以重量份数计包括如下成分：
组分A：野枸杞根15g，白狗屎15g，大黄15g，枯矾5g，冰片5g，樟脑5g；
组分B：地塞米松针剂3g，菌必治针剂1g，病毒唑针剂1g，维生素C 0.5g；
组分C：风油精3g，红霉素眼膏3g，华佗膏5g，复方酮康唑乳膏1g，狼毒软膏1g。
以上对本发明的具体实施例进行了详细描述，但其只是作为范例，本发明并不等同于以上描述的具体实施例。对于本领域技术人员而言，任何对本发明进行的等同修改和替代也都在本发明的范畴之中。因此，不脱离本发明的精神和范围下所做的均等变换和修改，都应涵盖在本发明的范围内。

Claims (3)

1.一种中西医结合清热解毒的外用药，其特征在于，包括组分A，组分B和组分C，各组分以重量份数计包括如下成分：
组分A：野枸杞根15-40份，白狗屎10-20份，大黄10-20份，枯矾5-15份，冰片5-15份，樟脑5-15份；
组分B：地塞米松针剂1-6份，菌必治针剂1-2份，病毒唑针剂1-5份，维生素C 0.5-1份；
组分C：风油精1-3份，红霉素眼膏1-3份，华佗膏1-5份，复方酮康唑乳膏1-5份，狼毒软膏1-5份。
2.一种根据权利要求1所述的中西医结合清热解毒外用药的制作方法，其特征在于，包括如下步骤：
S1.将组分A中的各原料磨碎打粉，混合均匀后，加香油拌匀成膏剂；
S2.将组分B中的各原料加入生理盐水中稀释，然后加入喷雾瓶内备用；
S3.将组分C中的各原料按比例混合，搅拌均匀备用。
3.根据权利要求1所述一种中西医结合清热解毒的外用药，其特征在于，所述药物的使用方法为先使用组分B的喷雾均匀喷洒至患处，然后分别将组分A或组分C的膏剂抹入患处，每日3-4次。
CN202110371368.9A 2021-04-07 2021-04-07 一种中西医结合清热解毒的外用药 Pending CN113082113A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110371368.9A CN113082113A (zh) 2021-04-07 2021-04-07 一种中西医结合清热解毒的外用药

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110371368.9A CN113082113A (zh) 2021-04-07 2021-04-07 一种中西医结合清热解毒的外用药

Publications (1)

Publication Number Publication Date
CN113082113A true CN113082113A (zh) 2021-07-09

Family

ID=76674721

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110371368.9A Pending CN113082113A (zh) 2021-04-07 2021-04-07 一种中西医结合清热解毒的外用药

Country Status (1)

Country Link
CN (1) CN113082113A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116327776A (zh) * 2022-12-12 2023-06-27 石中顺 酮康唑软膏及酮康唑软膏类似物治疗复发性口腔炎的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288672A (zh) * 2007-04-18 2008-10-22 陈成彬 治疗皮肤病的药物及其制备方法
CN110559259A (zh) * 2019-09-23 2019-12-13 郭小兵 一种治疗皮肤顽癣疾病的膏药

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288672A (zh) * 2007-04-18 2008-10-22 陈成彬 治疗皮肤病的药物及其制备方法
CN110559259A (zh) * 2019-09-23 2019-12-13 郭小兵 一种治疗皮肤顽癣疾病的膏药

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
魏晓琦等: "矾冰液湿敷治疗1-2级放射性皮炎的临床观察", 《中医药导报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116327776A (zh) * 2022-12-12 2023-06-27 石中顺 酮康唑软膏及酮康唑软膏类似物治疗复发性口腔炎的用途

Similar Documents

Publication Publication Date Title
CN103385926A (zh) 治疗妇科宫颈及阴道疾病的抗菌凝胶
CN113082113A (zh) 一种中西医结合清热解毒的外用药
CN101721527B (zh) 一种中药珠宝霜及其制备方法
WO2017036241A1 (zh) 一种祛痘中药组合物及其制备方法
CN1739808A (zh) 新型液体敷料
CN103462870A (zh) 蒲公英金银花祛痘面膜及制作方法
CN103463192B (zh) 复方对乙酰氨基酚注射液及其制备方法
CN102091287A (zh) 一种治疗皮肤湿疹的止痒霜
CN103990035A (zh) 一种治疗脚癣的皮肤外用软膏的配方
CN104666670A (zh) 治疗褥疮的中药组合物
CN106822321B (zh) 伤科黄水在制备治疗毛周角化症的药物中的应用
US20200323940A1 (en) Dietary supplements and use thereof on menses
CN100335086C (zh) 一种治疗黄水疮的药物
Jaiswal et al. Medical uses of Commiphora wightii
CN103202881A (zh) 一种治疗皮疹的外用剂组合物
CN104623168A (zh) 一种治疗皮疹红肿的外用中药
CN109364216B (zh) 一种具有活血化瘀功效的外敷药膏
CN103908558A (zh) 一种治疗痤疮的中药组合物及其制备方法和应用
CN102908440A (zh) 一种治疗湿疹的药膏
CN116270836A (zh) 一种治疗外阴白斑的外用药物组合物
CN104971162A (zh) 一种烧伤药膏及其制备方法
CN106728976A (zh) 一种防治草鱼出血病的组合物
CN105267737A (zh) 一种治疗皮肤过敏的药膏
CN116549538A (zh) 高温烧烫伤复方药物及其制备方法
CN101401882A (zh) 治疗痔疮的外敷药

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210709